4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-17-065248
Director acquired 62,500 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2017-12-12 | Conversion | +62,500 | 137,500 | D | ||
| Derivatives | |||||||
| SATO VICKI L Director | 2017-12-12 | Conversion · Series A-1 Preferred Stock | −62,500 | 0 | D | ||
Loading xslF345X03/doc4.xml…